Month: October 2019
Using PK/PD M&S for Pediatric Drug Development: Regulatory Insights into Practical Issues
This webinar addressed some of the challenges associated with pediatric drug development and the advantages (and limitations) that pediatric population PK modeling can provide.
Simcyp: 20 Years of Innovation
The consortium members have partnered with Simcyp and Certara during the past 20 years to advance the science of drug development through modeling & simulation
Supporting Efficient Infectious Disease Drug Development and Commercialization
Certara uses a unique set of disciplines and technologies to address the challenges that infectious disease drug programs face.
Certara Launches BaseCase Data Studio, Enabling Pharma and MedTech Clients to Conduct Advanced Data Analyses During Value-based Product Discussions
Oct 1, 2019BaseCase platform can now perform live statistical modeling and sophisticated data analyses, delivering evidence-based claims to support value messages during payer, provider and HCP discussions